--- title: "OXFORD BIOTHERAPEUTICS LTD — Ownership Dossier" canonical: https://whiteintel.dev/entity/eb14b786-0dc4-5f07-bada-16cffc1d3725 json: https://whiteintel.dev/api/public/dossier/eb14b786-0dc4-5f07-bada-16cffc1d3725 identifier: oo:GB-COH-04974481 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # OXFORD BIOTHERAPEUTICS LTD **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-04974481` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/eb14b786-0dc4-5f07-bada-16cffc1d3725 **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/eb14b786-0dc4-5f07-bada-16cffc1d3725 ## Ownership & control ### Owners / controllers - **SHARE NOMINEES LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/a9c64407-3eee-5f83-ba86-31c760a53e58 - **CATAPULT GROWTH FUND LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/9656e2b8-6b90-55ca-8fd0-23ee54cf2faa - **SOUTH EAST GROWTH FUND MANAGERS LIMITED** (beneficial owner) — 75% — https://whiteintel.dev/entity/747754d3-c695-5246-8079-68c07fcf2a09 - **OXFORD BIOTHERAPEUTICS LTD** (beneficial owner) — 50% — https://whiteintel.dev/entity/eb14b786-0dc4-5f07-bada-16cffc1d3725 - **Catapult Growth Fund Limited** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/1964fcac-510c-4b69-ad13-30408136174e - **Gkf Wealth Management Limited** (beneficial owner) — https://whiteintel.dev/entity/ba461acd-6a26-404e-86d2-944dd16eb937 - **South East Growth Fund Managers Limited** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/5be76c21-5dc3-48b5-b908-9b29c152069c - **SHARE NOMINEES LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/a9c64407-3eee-5f83-ba86-31c760a53e58 ### UBO chain (walk to the ultimate owner) A **114-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `04974481` - **Status:** active - **Type:** ltd - **Incorporated:** 2003-11-24 - **Registered office:** Suite A, Second Floor, The Schrodinger Building Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom - **SIC:** 72110, 72190, 74909 ### Officers - BIZZARI, Jean Pierre, Doctor — director · French,American · appointed 2016-12-14 - GOULD, Jason Lee — director · British · appointed 2020-12-15 - ROHLFF, Christian, Doctor — director · German · appointed 2003-12-11 - SEIZINGER, Bernd Robert — director · German · appointed 2016-12-14 - BARNES, Martin Paul, Dr — secretary · British · appointed 2005-03-23 · resigned 2008-10-30 - LAMBLE, Henry John, Dr — secretary · British · appointed 2008-11-14 · resigned 2013-04-18 - LIVADIOTIS, Maria Juliet — secretary · appointed 2013-09-12 · resigned 2014-06-12 - RIGBY, Andrew Pryce — secretary · appointed 2014-07-21 · resigned 2016-03-31 - RIGBY, Andrew Pryce — secretary · appointed 2013-04-18 · resigned 2013-09-12 - ZIMMERMAN, Alexandra — secretary · British · appointed 2004-05-07 · resigned 2005-03-23 - GW SECRETARIES LIMITED — corporate secretary · appointed 2003-11-24 · resigned 2004-05-07 - BARNES, Martin Paul, Dr — director · British · appointed 2005-10-19 · resigned 2008-11-27 - BEGLEY, Colin Glenn, Dr — director · Australian And Usa · appointed 2012-01-09 · resigned 2017-03-31 - BRADLEY, Daniel Thomas — director · British · appointed 2016-03-31 · resigned 2020-12-31 - FORSTER, Eliot Richard, Dr — director · British · appointed 2006-05-30 · resigned 2015-01-20 - HIBBERD, Christopher Richard — director · Canadian · appointed 2007-10-18 · resigned 2014-01-15 - MCHUTCHISON, John George — director · American · appointed 2017-05-24 · resigned 2023-04-24 - MOORE, Michael, Dr — director · British · appointed 2009-10-01 · resigned 2013-06-26 - MORTON, Bryan Geoffrey — director · British · appointed 2013-06-26 · resigned 2014-12-18 - PLATT, Albert — director · British · appointed 2004-07-25 · resigned 2005-04-29 ### Beneficial owners (Persons with Significant Control) - [Catapult Growth Fund Limited (As Gp For Catapult Growth Fund Limited Partnership)](https://whiteintel.dev/entity/1964fcac-510c-4b69-ad13-30408136174e) — 25–50% shares · corporate PSC · United Kingdom — since 2018-11-24 - [South East Growth Fund Managers Limited](https://whiteintel.dev/entity/5be76c21-5dc3-48b5-b908-9b29c152069c) — 50–75% shares · corporate PSC · United Kingdom — since 2018-11-24 - Gkf Wealth Management Limited — 25–50% votes · corporate PSC · United Kingdom — since 2018-11-24 - [Share Nominees Limited](https://whiteintel.dev/entity/a9c64407-3eee-5f83-ba86-31c760a53e58) — 25–50% shares · corporate PSC · England — ceased 2018-11-24 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/04974481 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/04974481 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **OXFORD BIOTHERAPEUTICS LTD** — https://whiteintel.dev/entity/eb14b786-0dc4-5f07-bada-16cffc1d3725 · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **OXFORD BIOTHERAPEUTICS LTD**. Human view: https://whiteintel.dev/entity/eb14b786-0dc4-5f07-bada-16cffc1d3725 · Structured JSON: https://whiteintel.dev/api/public/dossier/eb14b786-0dc4-5f07-bada-16cffc1d3725._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._